- Home
- IAG vs ICUI Comparison
IAG vs ICUI Comparison
Compare IAG & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IAG
- ICUI
- Stock Information
- Founded
- IAG 1990
- ICUI 1984
- Country
- IAG Canada
- ICUI United States
- Employees
- IAG N/A
- ICUI N/A
- Industry
- IAG Precious Metals
- ICUI Medical/Dental Instruments
- Sector
- IAG Basic Materials
- ICUI Health Care
- Exchange
- IAG Nasdaq
- ICUI Nasdaq
- Market Cap
- IAG 4.0B
- ICUI 3.4B
- IPO Year
- IAG 1996
- ICUI 1992
- Fundamental
- Price
- IAG $7.56
- ICUI $119.06
- Analyst Decision
- IAG Buy
- ICUI Strong Buy
- Analyst Count
- IAG 6
- ICUI 5
- Target Price
- IAG $8.61
- ICUI $196.75
- AVG Volume (30 Days)
- IAG 12.5M
- ICUI 213.0K
- Earning Date
- IAG 08-07-2025
- ICUI 08-07-2025
- Dividend Yield
- IAG N/A
- ICUI N/A
- EPS Growth
- IAG 405.77
- ICUI N/A
- EPS
- IAG 1.42
- ICUI N/A
- Revenue
- IAG $1,771,200,000.00
- ICUI $2,420,093,000.00
- Revenue This Year
- IAG $52.60
- ICUI N/A
- Revenue Next Year
- IAG $13.20
- ICUI N/A
- P/E Ratio
- IAG $5.44
- ICUI N/A
- Revenue Growth
- IAG 61.05
- ICUI 7.22
- 52 Week Low
- IAG $3.55
- ICUI $121.11
- 52 Week High
- IAG $8.38
- ICUI $196.26
- Technical
- Relative Strength Index (RSI)
- IAG 57.48
- ICUI 36.49
- Support Level
- IAG $6.69
- ICUI $125.07
- Resistance Level
- IAG $8.04
- ICUI $130.57
- Average True Range (ATR)
- IAG 0.27
- ICUI 4.30
- MACD
- IAG 0.08
- ICUI -0.22
- Stochastic Oscillator
- IAG 64.81
- ICUI 18.31
About IAG Iamgold Corporation
Iamgold Corp is a mid-tier gold mining company. The company operating gold mines are divided into geographic segments such as Cote Gold mine - Canada, Burkina Faso - Essakane mine, Westwood mine - Canada. The company's s non-gold mine segments are Exploration and evaluation and development, and Corporate - which includes royalty interests. The company generates the majority of its revenue from the Cote Gold mine segment.
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.